Prospects for Use of Ceftolosan-Tazobactam in Providing Medical Care to Victims in a Third-Level Hospital and during Inter-Hospital Medical Evacuation

Abstract

It is noted that nosocomial infections are a serious threat to the safety of hospital patients due to their high prevalence and high mortality rate. The prospects of using a new antibacterial drug ceftolosan-tazobactam as a starting empirical therapy in patients with a high risk of nosocomial infection caused by multidrug-resistant microorganisms in a level III hospital and during inter-hospital medical evacuation are considered.